Latest
-
Precision Cancer Medicines for Colon Cancer
Genomic testing identifies genetic targets that can be treated with precision cancer medicines avoiding chemotherapy
-
Daraxonrasib Shows Major Survival Benefit in Metastatic Pancreatic Cancer
Daraxonrasib, a first in class RAS(ON) inhibitor, has more than doubled overall survival versus chemotherapy in previously treated metastatic pancreatic cancer in the pivotal phase 3 RASolute 302 trial—early data that could reshape second line care once fully validated and reviewed.
Welcome to CancerConnect
CancerConnect is a unique resource that brings patients, caregivers, advocates and experts together – individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, and treatment and the support of other individuals being treated at some of the best cancer centers. CancerConnect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey. Search the over 7000 articles on the management of cancer.
